This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Biolase Inc (BIOL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 1.44M 2.54M 3.31M 1.69M
Receivables 11.13M 11.68M 8.90M 3.33M
Inventories 11.38M 11.14M 11.31M 6.99M
Other Current Assets 0.00 0.00 0.00 576.00K
Total Current Assets 25.85M 26.92M 25.33M 13.94M
Property, Plant & Equipment, Gross 8.80M 8.03M 8.31M 7.76M
Accumulated Depreciation & Depletion 6.97M 6.52M 7.16M 7.00M
Property, Plant & Equipment, Net 1.83M 1.51M 1.15M 755.00K
Intangibles 183.00K 300.00K 212.00K 342.00K
Other Non-Current Assets 249.00K 305.00K 187.00K 170.00K
Total Non-Current Assets 5.18M 5.06M 4.48M 4.20M
Liabilities & Shareholder Equity
Total Assets 31.04M 31.97M 29.81M 18.15M
Accounts Payable 8.56M 7.66M 7.80M 4.03M
Short Term Debt 4.63M 1.64M 0.00 2.62M
Other Current Liabilities 0.00 4.57M 165.00K 5.88M
Total Current Liabilities 21.94M 19.38M 16.28M 19.66M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 617.00K 663.00K 594.00K 544.00K
Other Non-Current Liabilities 1.00K 141.00K 362.00K 990.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 618.00K 804.00K 956.00K 1.53M
Total Liabilities 22.56M 20.18M 17.24M 21.19M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 8.48M 11.79M 12.57M -3.05M
Common Par 38.00K 34.00K 33.00K 27.00K
Additional Paid In Capital 148.87M 140.75M 138.51M 118.38M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -123.75M -112.27M -109.21M -104.73M
Treasury Stock -16.40M -16.40M -16.40M -16.40M
Other Equity Adjustments -274.00K -320.00K -360.00K -324.00K
Total Capitalization 8.48M 11.79M 12.57M -3.05M
Total Equity 8.48M 11.79M 12.57M -3.05M
Total Liabilities & Stock Equity 31.04M 31.97M 29.81M 18.15M
Total Common Shares Outstanding 35.37M 32.07M 31.78M 26.38M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 1.97M 2.01M 2.04M 2.13M
Basic Weighted Shares Outstanding 32.58M 32.10M 30.46M 26.48M
Diluted Weighted Shares Outstanding 32.58M 32.10M 30.46M 26.48M
Number of Employees 220 219 184 145
Number of Part-Time Employees 0 0 0 0
BIOL News

Analysts Ratings for BIOL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BIOL ANALYST REPORT

Brokerage Partners

BIOL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs